JP Patent

JP3125221B2 — ソファルコン含有固形製剤

Assigned to Taisho Pharmaceutical Co Ltd · Expires 2001-01-15 · 25y expired

What this patent protects

Patent listed against nilotinib-hydrochloride.

Drugs covered by this patent

nilotinib-hydrochloride (Nilotinib Hydrochloride) · Jan Beumer

Patent Metadata

Patent number: JP3125221B2
Jurisdiction: JP
Classification: —
Expires: 2001-01-15
Drug substance claim: No
Drug product claim: No
Assignee: Taisho Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.